352 followers
RT @FrontOncology: New research: Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Bi…
RT @FrontOncology: New research: Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Bi…
New research: Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers: Objectives We aimed to examine clinical data and baseline blood test results as potential predictive biomarkers… https://t.co/